Skip to main content
Top

International Journal of Clinical Oncology

Issue 4/2008

Content (17 Articles)

Introduction to Review Articles

Current topics and perspectives in bladder cancer research

Osamu Ogawa

Review Article

p53 and chemosensitivity in bladder cancer

Hiroyuki Nishiyama, Jun Watanabe, Osamu Ogawa

Review Article

Molecular pathogenesis of bladder cancer

Margaret A. Knowles

Review Article

Epigenetics in bladder cancer

Hideki Enokida, Masayuki Nakagawa

Review Article

Glycosylation in bladder cancer

Chikara Ohyama

Original Article

Evaluation of axillary status in patients with breast cancer using thin-section CT

Tadahiko Shien, Sadako Akashi-Tanaka, Miwa Yoshida, Takashi Hojo, Eriko Iwamoto, Kunihisa Miyakawa, Takayuki Kinoshita

Original Article

PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow

Shinichi Kinami, Takashi Fujimura, Eisuke Ojima, Sachio Fushida, Toshihiko Ojima, Hiroshi Funaki, Hideto Fujita, Hiroyuki Takamura, Itasu Ninomiya, Genichi Nishimura, Masato Kayahara, Tetsuo Ohta, Zen Yoh

Original Article

Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer

Faruk Tas, Duygu Derin, Nese Guney, Adnan Aydiner, Erkan Topuz

Original Article

Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review

Tsuguhisa Nashiro, Chiaki Yagi, Makoto Hirakawa, Morihiko Inamine, Yutaka Nagai, Kaoru Sakumoto, Wakana Tamaki, Kazuhiko Ogawa, Takafumi Toita, Yoichi Aoki

Original Article

The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancer

Hiroko Nogi, Tadashi Kobayashi, Isao Tabei, Kazumi Kawase, Yasuo Toriumi, Masafumi Suzuki, Toshiaki Morikawa, Ken Uchida

Original Article

Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer

Yoh Watanabe, Eiji Koike, Hidekatsu Nakai, Tomomaro Etoh, Hiroshi Hoshiai

Original Article

Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer

Junichiro Kawamura, Satoshi Nagayama, Akinari Nomura, Atsushi Itami, Hiroshi Okabe, Seiji Sato, Go Watanabe, Yoshiharu Sakai

Case Report

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate

Madoka Hamada, Kazuhide Ozaki, Tadashi Horimi, Akihito Tsuji, Yoshitsugu Nasu, Jun Iwata, Yusuke Nagata

Case Report

Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases

Soichiro Morinaga, Yuji Yamamoto, Nobuhiro Sugano, Hiroo Wada, Manabu Shiozawa, Makoto Akaike, Yukio Sugimasa

Case Report

Preoperatively undetected solitary bile duct hamartoma (von Meyenburg complex) associated with esophageal carcinoma

Kenji Mimatsu, Takatsugu Oida, Atsushi Kawasaki, Osamu Aramaki, Youichi Kuboi, Yoshihisa Katsura, Sadao Amano

Case Report

Cardiac metastases

Abrahim Al-Mamgani, Lizette Baartman, Margreet Baaijens, Ilse de Pree, Luca Incrocci, Peter C. Levendag

Case Report

Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil

Tsutomu Mizoshita, Hiromi Kataoka, Eiji Kubota, Yasuyuki Okamoto, Takaya Shimura, Yoshinori Mori, Tsuneya Wada, Naotaka Ogasawara, Makoto Sasaki, Takeshi Kamiya, Takashi Joh

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine